Investigation of Risk Factors Related to the Development of Hepatic Dysfunction in Patients with a Low and Moderate

Ayse Baysal1, Gonul Sagiroglu2, Mevlut Dogukan3

  • 1Pendik Bolge Hospital, Department of Anesthesiology and Reanimation, Istanbul, Turkey.

Insights

Low ejection fraction and extended aortic cross-clamp time are key risk factors for hepatic dysfunction after open-heart surgery. Valve surgeries present a higher risk of hyperbilirubinemia compared to coronary artery bypass grafting.

Area of Science:

  • Cardiology
  • Hepatology
  • Surgical Research

Background:

  • Hepatic dysfunction is a potential complication following open-heart surgery.
  • Identifying risk factors is crucial for patient management and improving outcomes.

Purpose of the Study:

  • To identify risk factors associated with hepatic dysfunction, specifically hyperbilirubinemia, in patients undergoing open-heart surgery.
  • To compare the incidence of hyperbilirubinemia between coronary artery bypass graft (CABG) and valve surgery procedures.

Main Methods:

  • Prospective investigation of 307 low-to-moderate cardiac risk patients undergoing CABG or valve surgery.
  • Monitoring of liver function tests (ALT, AST, ALP, TBil, GGT, albumin) preoperatively and postoperatively.
  • Logistic regression analysis to determine independent risk factors for postoperative hyperbilirubinemia.

Main Results:

  • Postoperative hyperbilirubinemia occurred in 4% of CABG patients and 8.4% of valve surgery patients.
  • Independent risk factors identified: low ejection fraction (EF), prolonged aortic cross-clamp (ACC) time, extended ICU stay, and longer extubation time.
  • Valve surgeries were associated with a significantly higher incidence of hyperbilirubinemia compared to CABG.

Conclusions:

  • Low ejection fraction and prolonged aortic cross-clamp time are significant independent risk factors for early postoperative hyperbilirubinemia in open-heart surgery with cardiopulmonary bypass.
  • Valve replacement surgeries demonstrate a higher frequency of postoperative hyperbilirubinemia than CABG procedures.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
93
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
45
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
62
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
52
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
378
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.2K